David Crews serves as Executive at CYTOMEDIX INC, where they oversee executive responsibilities. Since joining the company, David Crews has executed 12 insider transactions totaling $202.2K, demonstrating a bearish approach to their equity position. Their most recent transaction on Sep 5, 2008 involved purchasing 33,334 shares valued at $25.0K.
David Crews currently holds 694,957 shares of CYTOMEDIX INC (GTF), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, David Crews has been a net seller of GTF stock. They have purchased $46.1K and sold $156.1K worth of shares.
David Crews's most recent insider trade was on Sep 5, 2008, when they purchased 33,334 shares at $0.75 per share.
Get notified when new Form 4 filings are submitted
| $4.44 |
| Discretionary |
| Sep 28, 2007 | GTF | $17.3K | Sale | 4,500 | $3.84 | Discretionary |
| Sep 28, 2007 | GTF | $19.6K | Sale | 5,000 | $3.92 | Discretionary |
| Sep 28, 2007 | GTF | $18.8K | Sale | 5,000 | $3.75 | Discretionary |
| Sep 27, 2007 | GTF | $20.7K | Sale | 5,500 | $3.77 | Discretionary |
| Sep 27, 2007 | GTF | $9.3K | Sale | 2,500 | $3.72 | Discretionary |
| Sep 27, 2007 | GTF | $15.0K | Sale | 4,000 | $3.76 | Discretionary |
| Sep 27, 2007 | GTF | $5.6K | Sale | 1,500 | $3.71 | Discretionary |
| Sep 27, 2007 | GTF | $18.8K | Sale | 5,000 | $3.75 | Discretionary |
| Oct 17, 2006 | GTF | $21.1K | Purchase | 18,000 | $1.17 | Discretionary |
| Sep 22, 2006 | GTF | $0 | Gift | 35,088 | $N/A | Discretionary |